In addition to the LPL gene, crucial endogenous regulators of LPL activity are associated with CAD, including APOC3 (Pollin et al., 2008; Willer et al., 2008; Crosby et al., 2014). The gene discussed is APOC3; the disease is coronary artery disorder.